Research progress and prospects of circulating tumor cells in hepatocellular carcinoma

Hepatobiliary Pancreat Dis Int. 2022 Dec;21(6):514-515. doi: 10.1016/j.hbpd.2022.07.001. Epub 2022 Jul 9.

Authors

Chang-Can Li¹, Hua-Yu Yang¹, Yi-Lei Mao²

Affiliations

¹ Department of Liver Surgery, Peking Union Medical College (PUMC) Hospital, PUMC & Chinese Academy of Medical Sciences (CAMS), Beijing 100730, China.
² Department of Liver Surgery, Peking Union Medical College (PUMC) Hospital, PUMC & Chinese Academy of Medical Sciences (CAMS), Beijing 100730, China. Electronic address: pumch-liver@hotmail.com.

PMID: 35853804
DOI: 10.1016/j.hbpd.2022.07.001

No abstract available

Publication types

Editorial
Comment

MeSH terms

Biomarkers, Tumor
Carcinoma, Hepatocellular* / pathology
Humans
Liver Neoplasms* / pathology
Neoplastic Cells, Circulating*

Substances

Biomarkers, Tumor